Compare GSK plc (GSK) vs Southwest Airlines Co (LUV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Southwest Airlines Co — how do they compare? GSK plc trades at $52.65 (market cap $101.34B), while Southwest Airlines Co trades at $49.49 (market cap $24.07B). The key difference: GSK plc is far larger — about 4.2× Southwest Airlines Co's market cap, and GSK plc pays the higher dividend (3.49%). Which is the better fit depends on your goals.
| GSK | LUV | |
|---|---|---|
Market Cap | $101.34B | $24.07B |
Sector | Health | Industrials |
52-Week High | $61.18 | $54.80 |
52-Week Low | $36.20 | $29.06 |
Enterprise Value | $121.95B | $27.14B |
Dividend Yield | 3.49% | 1.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $52.64, up 2.7% on the day, with a bearish technical signal despite recent earnings beats. The company reported Q1 2026 EPS of $1.24, beating estimates of $1.16, and maintains strong profitability with a 17.78% net income margin. Positive clinical trial results for Jemperli in rectal cancer and FDA approval for Utebzi highlight pipeline strength, while a pending acquisition of Nuvalent, Inc. signals strategic expansion.
GSK offers value with a P/E of 13.71 and stable cash flows, but faces risks from clinical setbacks, as seen in the terminated Alector partnership. Analyst sentiment is mixed with 31% buy ratings, reflecting cautious optimism amid competitive and regulatory pressures. The stock's outlook hinges on execution of growth initiatives and pipeline developments.
Southwest Airlines (LUV) trades at $49.33, up 3.72% today, with a bullish technical signal from moving averages and neutral oscillators. The company reported mixed recent earnings, beating in Q3 and Q4 2025 but missing in Q1 2026, with Q2 2026 results expected soon. Financials show modest revenue growth to $28.06B in 2025 but declining net income margins, while cash flow trends indicate significant net outflows. Analyst consensus is a $52.47 price target with a divided rating split between Buy and Hold.
LUV's outlook is cautiously optimistic, supported by resilient travel demand and potential earnings growth, but faces headwinds from fuel cost volatility and execution risks. The stock offers value with a P/S of 0.92, yet high fuel expenses and competitive pressures pose challenges for sustained profitability, making it a hold for risk-aware investors awaiting Q2 earnings clarity.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Southwest Airlines Co
Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite expanding into longer routes and business travel, the airline still specializes in short-haul leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
Read more on LUV →
